Home › Funds › Occam Crest Management LP › PGEN

Occam Crest Management LP position in PGEN

PRECIGEN INC · Health Care

Occam Crest Management LP reported holding 2,721,521 shares of PGEN (PRECIGEN INC) in its Q3 2026 13F filing — a position valued at US$23.3M, representing 13.14% of its reported portfolio and ranking #1 among its reported holdings. Occam Crest Management LP has disclosed PGEN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)2.72M sh
Reported value held$23.30M
Portfolio Weight13.14%
First reportedQ3 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Occam Crest Management LP's PGEN position evolved

Occam Crest Management LP first disclosed a stake in PGEN in Q3 2025 at 2,000 shares (US$658K). The position peaked in Q3 2026 at 2,721,521 shares, worth US$23.3M. Across 5 filings, Occam Crest Management LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,721,521 shares valued at US$23.3M — an increase of 2,686,021 shares quarter over quarter.. Notable position changes include a 174987% increase in Q4 2025 (shares fell 7% over the following quarter), a 99% trim in Q2 2026 (shares rose 50% over the following quarter), a 7566% increase in Q3 2026 (shares fell 47% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 2.00K $658.00K New
Q4 2025 3.50M $14.64M Add
Q1 2026 4.27M $16.52M Add
Q2 2026 35.50K $2.49M Reduce
Q3 2026 2.72M $23.30M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PGEN and 13F data

PGEN (PRECIGEN INC) is a Health Care company. 68 other funds we track also report a position in PGEN — the largest reported positions include Patient Capital Management, LLC (US$153.7M), TANG CAPITAL MANAGEMENT LLC (US$36.6M), Boxer Capital Management, LLC (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PGEN

All PGEN fund holders →

FAQ

How long has Occam Crest Management LP held PGEN?

Occam Crest Management LP has disclosed PGEN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Occam Crest Management LP's current position in PGEN?

As of Q3 2026, Occam Crest Management LP holds 2.72M shares of PGEN (PRECIGEN INC), valued at $23.30M, representing 13.14% of its reported portfolio and ranking #1.

Has Occam Crest Management LP been buying or selling PGEN?

In the latest 13F filing (Q3 2026), Occam Crest Management LP increased its position in PGEN. The position peaked in Q3 2026 at 2.72M shares.

Which other funds hold PGEN?

Other major institutional holders of PGEN include Patient Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Boxer Capital Management, LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.